Annual ROA
-45.21%
-7.96%-21.37%
31 December 2023
Summary:
Keros Therapeutics annual return on assets is currently -45.21%, with the most recent change of -7.96% (-21.37%) on 31 December 2023. During the last 3 years, it has fallen by -12.86% (-39.75%). KROS annual ROA is now -828.34% below its all-time high of -4.87%, reached on 31 December 2018.KROS ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-40.96%
+1.19%+2.82%
30 September 2024
Summary:
Keros Therapeutics quarterly return on assets is currently -40.96%, with the most recent change of +1.19% (+2.82%) on 30 September 2024. Over the past year, it has increased by +2.84% (+6.48%). KROS quarterly ROA is now -75.12% below its all-time high of -23.39%, reached on 31 December 2021.KROS Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS ROA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -21.4% | +6.5% |
3 y3 years | -39.8% | -49.3% |
5 y5 years | -828.3% | - |
KROS ROA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -101.9% | at low | -75.1% | +6.6% |
5 y | 5 years | -828.3% | +29.7% | -75.1% | +63.6% |
alltime | all time | -828.3% | +29.7% | -75.1% | +63.6% |
Keros Therapeutics ROA History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -40.96%(-2.8%) |
June 2024 | - | -42.15%(+1.1%) |
Mar 2024 | - | -41.68%(-5.0%) |
Dec 2023 | -45.21%(+21.4%) | -43.87%(+0.2%) |
Sept 2023 | - | -43.80%(+5.7%) |
June 2023 | - | -41.44%(+0.2%) |
Mar 2023 | - | -41.37%(+0.9%) |
Dec 2022 | -37.25% | -41.01%(+20.1%) |
Sept 2022 | - | -34.14%(+3.3%) |
June 2022 | - | -33.05%(+20.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | -27.44%(+17.3%) |
Dec 2021 | -22.39%(-30.8%) | -23.39%(-14.7%) |
Sept 2021 | - | -27.43%(+7.2%) |
June 2021 | - | -25.59%(-9.1%) |
Mar 2021 | - | -28.16%(-21.8%) |
Dec 2020 | -32.35%(-49.7%) | -36.02%(-13.4%) |
Sept 2020 | - | -41.57%(+6.3%) |
June 2020 | - | -39.12%(-33.5%) |
Mar 2020 | - | -58.83%(-47.8%) |
Dec 2019 | -64.31%(+1220.5%) | -112.61% |
Dec 2018 | -4.87% | - |
FAQ
- What is Keros Therapeutics annual return on assets?
- What is the all time high annual ROA for Keros Therapeutics?
- What is Keros Therapeutics annual ROA year-on-year change?
- What is Keros Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Keros Therapeutics?
- What is Keros Therapeutics quarterly ROA year-on-year change?
What is Keros Therapeutics annual return on assets?
The current annual ROA of KROS is -45.21%
What is the all time high annual ROA for Keros Therapeutics?
Keros Therapeutics all-time high annual return on assets is -4.87%
What is Keros Therapeutics annual ROA year-on-year change?
Over the past year, KROS annual return on assets has changed by -7.96% (-21.37%)
What is Keros Therapeutics quarterly return on assets?
The current quarterly ROA of KROS is -40.96%
What is the all time high quarterly ROA for Keros Therapeutics?
Keros Therapeutics all-time high quarterly return on assets is -23.39%
What is Keros Therapeutics quarterly ROA year-on-year change?
Over the past year, KROS quarterly return on assets has changed by +2.84% (+6.48%)